Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Ovarian Carcinosarcoma 1Advanced Ovarian Cancer 1

Interventions

Saline Solution 3Carboplatin 2Bevacizumab 2talazoparib 1stenoparib 1senaparib 1sargramostim 1olaparib 1niraparib 1liposomal doxorubicin 1Tranexamic Acid 1Ropivacaine 1Paclitaxel 1Observation 1Neoadjuvant Therapy 1Hyperthermic Intraperitoneal Chemotherapy 1Antineoplastic Agents 11-dodecylpyridoxal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Ovarian Cancer × Antineoplastic Agents × Gynecologic × Clear all
NCT03611179 2018-08-02

Upfront Treatment With Chemotherapy and Bevacizumab in Advanced Ovarian Cancer

Assiut University

Phase 2 Unknown
40 enrolled
Gynecologic

Advanced Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡